CoChat

Associations of Steroid Sex Hormones and Sex Hormone–Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis

Muka, Taulant, Nano, Jana, Jaspers, Loes, Meun, Cindy, Bramer, Wichor M., Hofman, Albert, Dehghan, Abbas, Kavousi, Maryam, Laven, Joop S.E., Franco, Oscar H. · 2017 · Diabetes
Cited by 140

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

It remains unclear whether endogenous sex hormones (ESH) are associated with risk of type 2 diabetes (T2D) in women. Data of 3,117 postmenopausal women participants of the Rotterdam Study were analyzed to examine whether ESH and sex hormone–binding globulin (SHBG) were associated with the risk of incident T2D. Additionally, we performed a systematic review and meta-analysis of studies assessing the prospective association of ESH and SHBG with T2D in women. During a median follow-up of 11.1 years, we identified 384 incident cases of T2D in the Rotterdam Study. No association was observed between total testosterone (TT) or bioavailable testosterone (BT) with T2D. SHBG was inversely associated with the risk of T2D, whereas total estradiol (TE) was associated with increased risk of T2D. Similarly, in the meta-analysis of 13 population-based prospective studies involving more than 1,912 incident T2D cases, low levels of SHBG and high levels of TE were associated with increased risk of T2D, whereas no associations were found for other hormones. The association of SHBG with T2D did not change by menopause status, whereas the associations of ESH and T2D were based only in postmenopausal women. SHBG and TE are independent risk factors for the development of T2D in women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db16-0473

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Atsma, 2006, Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis, Menopause, 13, 265, 10.1097/01.gme.0000218683.97338.ea · DOI · Paper page
  2. Liu, 2001, Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation, Am J Epidemiol, 154, 489, 10.1093/aje/154.6.489 · DOI · Paper page
  3. Brand, 2013, Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study, Diabetes Care, 36, 1012, 10.2337/dc12-1020 · DOI · Paper page
  4. Gambineri, 2012, Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study, Diabetes, 61, 2369, 10.2337/db11-1360 · DOI · Paper page
  5. Kalish, 2003, Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial, J Clin Endocrinol Metab, 88, 1646, 10.1210/jc.2002-021375 · DOI · Paper page
  6. Brand, 2010, Testosterone, SHBG and cardiovascular health in postmenopausal women, Int J Impot Res, 22, 91, 10.1038/ijir.2009.64 · DOI
  7. Golden, 2007, Endogenous sex hormones and glucose tolerance status in postmenopausal women, J Clin Endocrinol Metab, 92, 1289, 10.1210/jc.2006-1895 · DOI · Paper page
  8. Hofman, 2013, The Rotterdam Study: 2014 objectives and design update, Eur J Epidemiol, 28, 889, 10.1007/s10654-013-9866-z · DOI · Paper page
  9. Leening, 2012, Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study, Eur J Epidemiol, 27, 173, 10.1007/s10654-012-9668-8 · DOI · Paper page
  10. World Health Organization, 2006, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation, 1
  11. Rubin, 1987, Multiple imputation for nonresponse in surveys, Invest Radiol
  12. Rubin, Multiple Imputation for Nonresponse in Surveys, 10.1002/9780470316696 · DOI · Paper page
  13. Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  14. Soriguer, 2012, Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study, Eur J Invest, 42, 79, 10.1111/j.1365-2362.2011.02559.x · DOI · Paper page
  15. Boyd-Woschinko, 2007, Androgen excess is associated with insulin resistance and the development of diabetes in African American women, J Cardiometab Syndr, 2, 254, 10.1111/j.1559-4564.2007.06561.x · DOI
  16. Okubo, 2000, Association of sex hormone-binding globulin and insulin resistance among Japanese-American subjects, Diabetes Res Clin Pract, 47, 71, 10.1016/S0168-8227(99)00106-0 · DOI
  17. Mather, 2015, Steroid sex hormones, sex hormone-binding globulin, and diabetes incidence in the Diabetes Prevention Program, J Clin Endocrinol Metab, 100, 3778, 10.1210/jc.2015-2328 · DOI · Paper page
  18. Wang, 2015, Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates, Int J Epidemiol, 44, 623, 10.1093/ije/dyv093 · DOI · Paper page
  19. Zhao, 2005, Study on the (TAAAA)n repeat polymorphism in sex hormone-binding globulin gene and the SHBG serum levels in putative association with the glucose metabolic status of Chinese patients suffering from polycystic ovarian syndrome in Shandong province, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 22, 644
  20. Rosner, 1999, Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane, J Steroid Biochem Mol Biol, 69, 481, 10.1016/S0960-0760(99)00070-9 · DOI · Paper page
  21. Catalano, 2005, Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells, Mol Cell Endocrinol, 230, 31, 10.1016/j.mce.2004.11.005 · DOI
  22. Fortunati, 2010, Sex hormone-binding globulin (SHBG), estradiol and breast cancer, Mol Cell Endocrinol, 316, 86, 10.1016/j.mce.2009.09.012 · DOI
  23. Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 138, 1, 10.7326/0003-4819-138-1-200301070-00005 · DOI · Paper page
  24. Bonds, 2006, The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial, Diabetologia, 49, 459, 10.1007/s00125-005-0096-0 · DOI · Paper page
  25. Espeland, 1998, Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions, Diabetes Care, 21, 1589, 10.2337/diacare.21.10.1589 · DOI · Paper page
  26. Zhang, 2002, The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women: the Strong Heart Study, Diabetes Care, 25, 500, 10.2337/diacare.25.3.500 · DOI · Paper page
  27. Strandberg, 2003, Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women, Am J Cardiol, 92, 212, 10.1016/S0002-9149(03)00542-3 · DOI
  28. Decensi, 2002, Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women, Circulation, 106, 1224, 10.1161/01.CIR.0000028463.74880.EA · DOI · Paper page
  29. Lindheim, 1993, A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin, Fertil Steril, 60, 664, 10.1016/S0015-0282(16)56218-9 · DOI · Paper page
  30. Goodman-Gruen, 2000, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women, Diabetes Care, 23, 912, 10.2337/diacare.23.7.912 · DOI · Paper page
  31. Davis, 2012, Understanding weight gain at menopause, Climacteric, 15, 419, 10.3109/13697137.2012.707385 · DOI · Paper page

Cited by

See all 140

Metadata

Authors
Muka, T., Nano, J., Jaspers, L., Meun, C., Bramer, W. M., Hofman, A., Dehghan, A., Kavousi, M., Laven, J. S. E., & Franco, O. H.
Venue
Diabetes
Published
2016-10-10
Volume
66
Issue
3
Pages
577-586
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2531432849
Cited by
140
References
16
FWCI
7.50
Type
journal article
Language
en
Open access
closed
Funders
Metagenics Inc

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.